Search filters

List of works by Nikolai Podoltsev

A case of acute myeloid leukemia with unusual germline <i>CEBPA</i> mutation: lessons learned about mutation detection, location, and penetrance

scientific article published on 19 December 2020

A highly efficient and faithful MDS patient-derived xenotransplantation model for pre-clinical studies

scientific article published in Nature Communications

Allogeneic hematopoietic cell transplantation following the use of hypomethylating agents among patients with relapsed or refractory AML: Findings from an international retrospective study.

scientific article published on 9 April 2018

Counseling patients with higher-risk MDS regarding survival with azacitidine therapy: are we using realistic estimates?

scientific article

Diet and Risk of Myeloproliferative Neoplasms in Older Individuals from the NIH-AARP Cohort

scientific article published on 31 August 2020

Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial

scientific article published on 03 May 2019

Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial

scientific article published on 24 August 2017

Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort

scientific article published on 01 April 2018

Interferon alpha therapy in essential thrombocythemia and polycythemia vera-a systematic review and meta-analysis

scientific article published on 01 September 2020

Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study

scientific article published on 04 March 2020

Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia

scientific article published on 02 July 2018

Sequencing of novel agents in relapsed/refractory B-cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia

scientific article published on 01 December 2020

Temporal patterns and predictors of receiving no active treatment among older patients with acute myeloid leukemia in the United States: A population-level analysis

scientific article published on 04 September 2019

Paulina is supported by:

About Paulina

Help